Agreed. As one could expect, TLX has become a much more stable and well-behaved stock since 2024, compared to previous years.
A solid revenue stream + beating estimates + ASX100 approaching on the horizon + TLX591 positive data + a better understanding of TLX by the market + a great momentum for precision radiation and biotech, etc... certainly helped a lot!
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS, page-173
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.67 |
Change
0.390(2.13%) |
Mkt cap ! $6.164B | |||
| Open | High | Low | Value | Volume |
| $18.40 | $18.84 | $18.12 | $12.92M | 700.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 180 | $18.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.67 | 607 | 3 |
View Market Depth
| Last trade - 13.16pm 25/06/2024 (20 minute delay) ? |
| TLX (ASX) Chart |